Your browser doesn't support javascript.
loading
ERG orchestrates chromatin interactions to drive prostate cell fate reprogramming.
Li, Fei; Yuan, Qiuyue; Di, Wei; Xia, Xinyi; Liu, Zhuang; Mao, Ninghui; Li, Lin; Li, Chunfeng; He, Juan; Li, Yunguang; Guo, Wangxin; Zhang, Xiaoyu; Zhu, Yiqin; Aji, Rebiguli; Wang, Shangqian; Tong, Xinyuan; Ji, Hongbin; Chi, Ping; Carver, Brett; Wang, Yong; Chen, Yu; Gao, Dong.
Afiliación
  • Li F; State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Yuan Q; University of Chinese Academy of Sciences, Beijing, China.
  • Di W; Center for Excellence in Mathematical Sciences (CEMS), National Center for Mathematics and Interdisciplinary Sciences (NCMIS), Key Laboratory of Management, Decision and Information Systems (MDIS)., Academy of Mathematics and Systems Science, National Center for Mathematics and Interdisciplinary Sci
  • Xia X; School of Mathematical Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, China.
  • Liu Z; State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Mao N; University of Chinese Academy of Sciences, Beijing, China.
  • Li L; State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Li C; University of Chinese Academy of Sciences, Beijing, China.
  • He J; State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Li Y; University of Chinese Academy of Sciences, Beijing, China.
  • Guo W; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Zhang X; State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Zhu Y; University of Chinese Academy of Sciences, Beijing, China.
  • Aji R; State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Wang S; University of Chinese Academy of Sciences, Beijing, China.
  • Tong X; State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Ji H; University of Chinese Academy of Sciences, Beijing, China.
  • Chi P; State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Carver B; University of Chinese Academy of Sciences, Beijing, China.
  • Wang Y; State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Chen Y; University of Chinese Academy of Sciences, Beijing, China.
  • Gao D; State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
J Clin Invest ; 130(11): 5924-5941, 2020 11 02.
Article en En | MEDLINE | ID: mdl-32701507
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteínas Oncogénicas / Células Epiteliales / Reprogramación Celular / Regulador Transcripcional ERG Límite: Animals Idioma: En Revista: J Clin Invest Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteínas Oncogénicas / Células Epiteliales / Reprogramación Celular / Regulador Transcripcional ERG Límite: Animals Idioma: En Revista: J Clin Invest Año: 2020 Tipo del documento: Article País de afiliación: China